Project Number 2020SW Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2020 View Full Project Details for Analyses of Chronic Efficacy Studies with GSM 776890 for Submission of Pre-IND Brochure to FDA Prior to Pre-IND Meeting and IND Filing for SAD/MAD Phase I Safety/Toxicity and for Phase II and III Efficacy Clinical Trials to Support the NDA Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator Wagner, Steve Principal Investigator Wagner, Steve Awardee Organization University of California, San Diego Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement 2020 Research Grants FY Overall Cost $259,366 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
